Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future

被引：8
|
作者：
Gao, Feng [1 ]
Chen, Gang [2 ,3 ,4 ]
Byrne, Christopher D. [5 ,6 ]
Targher, Giovanni [7 ,8 ]
Cheung, Tan To [9 ]
Zheng, Ming-Hua [10 ,11 ,12 ,13 ]
机构：
[1] Wenzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Wenzhou, Peoples R China
[3] Wenzhou Med Univ, Key Lab Diag & Treatment Severe Hepatopancreat Dis, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Hepatobiliary Pancreat Tumor Bioengn Cross Int Joi, Affiliated Hosp 1, Wenzhou, Peoples R China
[5] Univ Hosp Southampton, Southampton Natl Inst Hlth & Care Res, Biomed Res Ctr, Southampton, England
[6] Univ Southampton, Southampton Gen Hosp, Southampton, England
[7] Univ Verona, Dept Med, Verona, Italy
[8] IRCCS Sacro Cuore Don Calabria Hosp, I-37024 Negrar Di Valpolicella, Italy
[9] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Peoples R China
[10] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, NAFLD Res Ctr, Wenzhou, Peoples R China
[11] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[12] Key Lab Diag & Treatment Dev Chron Liver Dis Zheji, Wenzhou, Peoples R China
[13] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, MAFLD Res Ctr, 2 Fuxue Lane, Wenzhou 325000, Peoples R China
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2023年 / 12卷 / 06期
基金：
中国国家自然科学基金;
关键词：
Metabolic dysfunction-associated fatty liver disease (MAFLD); metabolic dysfunction-associated steatotic liver disease; nonalcoholic fatty liver disease; hepatocellular carcinoma (HCC); epidemiology;
D O I：
10.21037/hbsn-23-539
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：945 / 948
页数：4
相关论文
共 50 条
  • [21] Therapeutic developments in metabolic dysfunction-associated fatty liver disease
    Shi, Yiwen
    Fan, Jiangao
    CHINESE MEDICAL JOURNAL, 2022, 135 (09) : 1009 - 1018
  • [22] Therapeutic developments in metabolic dysfunction-associated fatty liver disease
    Shi Yiwen
    Fan Jiangao
    中华医学杂志英文版, 2022, 135 (09) : 1009 - 1018
  • [23] Cardiometabolic characterization in metabolic dysfunction-associated fatty liver disease
    Perdomo, Carolina M.
    Nunez-Cordoba, Jorge M.
    Ezponda, Ana
    Mendoza, Francisco J.
    Ampuero, Javier
    Bastarrika, Gorka
    Fruhbeck, Gema
    Escalada, Javier
    FRONTIERS IN MEDICINE, 2022, 9
  • [24] Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
    Fouad, Yasser
    Alboraie, Mohamed
    Shiha, Gamal
    HEPATOLOGY INTERNATIONAL, 2024, 18 (SUPPL 2) : 827 - 833
  • [25] The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease
    Goya, Takeshi
    Imoto, Koji
    Tashiro, Shigeki
    Aoyagi, Tomomi
    Takahashi, Motoi
    Kurokawa, Miho
    Suzuki, Hideo
    Tanaka, Masatake
    Kato, Masaki
    Kohjima, Motoyuki
    Ogawa, Yoshihiro
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (01) : 20 - 26
  • [26] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Ting-Yao Wang
    Rui-Fang Wang
    Zhi-Ying Bu
    Giovanni Targher
    Christopher D. Byrne
    Dan-Qin Sun
    Ming-Hua Zheng
    Nature Reviews Nephrology, 2022, 18 : 259 - 268
  • [27] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [28] Metabolic dysfunction-associated fatty liver disease subgroups and risk of hepatocellular carcinoma and mortality in patients with chronic viral hepatitis
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    JOURNAL OF HEPATOLOGY, 2022, 77 : S100 - S100
  • [29] Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma
    Xiong, Ke-Gong
    Ke, Kun-Yu
    Kong, Jin-Feng
    Lin, Tai-Shun
    Lin, Qing-Biao
    Lin, Su
    Zhu, Yue-Yong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [30] Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
    Fassio, Eduardo
    Barreyro, Fernando J.
    Perez, M. Soledad
    Davila, Diana
    Landeira, Graciela
    Gualano, Gisela
    Ruffillo, Gabriela
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (02) : 354 - 371
12345